On May 29, 2018 Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, reported that management will present company overviews at the following conferences (Press release, Alnylam, MAY 29, 2018, View Source [SID1234527057]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bernstein 34th Annual Strategic Decisions Conference onFriday, June 1, 2018 at 9:00 am ET at the Grand Hyatt in New York City
Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018 at 4:00 pm ET at the Grand Hyatt in New York City
Goldman Sachs 39th Annual Global Healthcare Conference onThursday, June 14, 2018 at 9:20 am PT (12:20 pm ET) at the Terranea Resort in Rancho Palos Verdes, California

A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.